Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis

Wei Zheng,Shixiong Li,Zhongliang Shi,Kailing Su,Yu Ding,Luyue Zhang,Qian Tang,Jiani Han,Han Zhao,Fengwei Wang,Hongru Zhang and Zhangyong Hong
DOI: https://doi.org/10.1186/s12951-024-02837-2
IF: 10.2
2024-09-14
Journal of Nanobiotechnology
Abstract:Tumor neoantigen peptide-based vaccines, systemic immunotherapies that enhance antitumor immunity by activating and expanding antigen-specific T cells, have achieved remarkable results in the treatment of a variety of solid tumors. However, how to effectively deliver neoantigens to induce robust antitumor immune responses remains a major obstacle.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?